Ulcerative colitis is a chronic inflammatory bowel disease characterized by inflammation and ulcers in the lining of the colon and rectum. Symptoms include abdominal pain, diarrhea (often bloody), rectal bleeding, urgency to defecate, and weight loss. Treatment typically involves medications to reduce inflammation, manage symptoms, and induce remission, along with dietary changes, lifestyle modifications, and in severe cases, surgery to remove the affected colon.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
Ulcerative Colitis is among the most common forms of inflammatory bowel disease, with approximately 1.6 million Americans currently diagnosed. At Leapcure, our mission is to empower individuals and their advocates by offering valuable resources, facilitating connections with support groups, and enabling access to research initiatives.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...